We have received intimation from Mr. Akash Sethi (Promoter & Joint Managing Director) pursuant to Regulation 29(2) of the SEBI (SAST) Regulations regarding acquisition of 1,78,000 Equity Shares of Shree Pacetronix Limited (“Target Company”) on June 08, 2026, through an off market transfer from Bio Pace Technology INC. In this regard we are submitting herewith disclosure received from Mr. Akash Sethi pursuant to Regulation 29(2) of the SEBI (SAST) Regulations. Kindly take the same on record.
In terms of Regulation 30 of the SEBI Listing Regulations, as amended and SEBI Circular dated January 30, 2026, please find enclosed herewith the newspaper advertisement pertaining to the opening of special window for re-lodgement of the transfer request of physical shares published on June 10, 2026 in the following newspapers: 1. Free Press 2. Choutha Sansar This is for your information and record.
In terms of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/38/13/ (4)2026-MIRSD-POD/I/4298/2026 dated February 6, 2026 (the “SEBI Circular”) as amended from time to time, please find enclosed copy of letter to be dispatched to shareholders holding shares in physicals form. The Shareholders holding shares in physical mode are requested to furnish their PAN, KYC, Bank Details and Nomination details for updating to registrar and Share transfer Agent i.e. Ankit Consultancy Private Limited. You are requested to please take on record the above said information for your reference and further needful.
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/ CFD/ CMD1/162/2019 dated December 24, 2019, a statement confirming that there is no deviation(s) or variation(s) in utilization of funds raised through Preferential Issue for the quarter and year ended March 31, 2026. The said statement was reviewed by the Audit Committee and taken on record by the Board. You are requested to please take the same on record.
Non Applicability of Annual Secretarial Compliance Report as specified in SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for the Year Ended 31st March, 2026
Kindly find enclosed herewith the extracts of Newspaper Publication Pursuant to Reg 47 of SEBI (LODR) Regulations, 2015 of the Audited Standalone & Consolidated Financial Results for the quarter & financial year ended on 31.03.2026 which has been approved by the Board at their meeting held on 25.05.2026 and published today i.e. 26.05.2026 in the following newspapers: 1. Free Press 2. Choutha Sansar This is for your information and record.
Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors, in their meeting held on 25th May, 2026, have considered and approved the following matters: 1. On the recommendation of the Audit Committee, the Board of Directors considered and approved the appointment of M/s Apeksha Medatwal & Associates (FRN-033661C) as Internal Auditor of the Company. (Brief profile enclosed herewith as Annexure A) 2.On the recommendation of the Audit Committee, and subject to the approval of the shareholders, the Board of Directors considered and approved the appointment of M/s Agarwal Patel & Sinhal (Formally known as Bharat Kumar Agarwal & Co.) Chartered Accountants, Indore (FRN: 012245C) as Statutory Auditors of the Company. (Brief profile enclosed herewith as Annexure B).
Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors, in their meeting held on 25th May, 2026, have considered and approved the following matters: 1. On the recommendation of the Audit Committee, the Board of Directors considered and approved the appointment of M/s Apeksha Medatwal & Associates (FRN-033661C) as Internal Auditor of the Company. (Brief profile enclosed herewith as Annexure A) 2.On the recommendation of the Audit Committee, and subject to the approval of the shareholders, the Board of Directors considered and approved the appointment of M/s Agarwal Patel & Sinhal (Formally known as Bharat Kumar Agarwal & Co.) Chartered Accountants, Indore (FRN: 012245C) as Statutory Auditors of the Company. (Brief profile enclosed herewith as Annexure B).
Pursuant to Reg 30 read with Schedule III of the SEBI (LODR) Reg, 2015, we would like to inform you that the BOD, in their meeting held on 25.05.2026, have considered and approved the following matters: 1. On the recommendation of the Audit Committee, the Board of Directors considered and approved the appointment of M/s Apeksha Medatwal & Associates as Internal Auditor of the Co for the FY 2026-2027. (Brief profile enclosed herewith as Annexure A) 2. On the recommendation of the Audit Committee, and subject to the approval of the shareholders, the BOD considered and approved the appointment of M/s Agarwal Patel & Sinhal Chartered Accountants, Indore as Statutory Auditors of the Company. (Brief profile enclosed herewith as Annexure B).
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 5.86 | 5.23 | 4.30 | 6.65 | 4.85 | 4.04 | 3.63 | 4.28 | 5.34 | 6.59 | 4.33 | 5.37 |
| YOY Revenue Growth % | 74.9% | 25.35% | -17.6% | -11.52% | -17.18% | -22.73% | -15.62% | -35.64% | 10.07% | 63% | 19.57% | 25.41% |
| Other Income | 0.04 | 0.02 | 0.03 | 0.05 | 0.05 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | 0.05 |
| Total Income | 5.91 | 5.25 | 4.33 | 6.70 | 4.91 | 4.06 | 3.65 | 4.31 | 5.37 | 6.62 | 4.36 | 5.41 |
| Total Expenses + | 4.72 | 4.39 | 3.77 | 4.68 | 4.40 | 4.01 | 3.81 | 3.66 | 4.48 | 4.87 | 4.20 | 4.00 |
| Cost of Materials Consumed | 2.25 | 2.40 | 1.96 | 1.78 | 1.70 | 1.41 | 1.22 | 1.66 | 1.19 | 1.52 | 1.36 | 1.64 |
| Employee Benefit Expense | 0.95 | 1.00 | 0.99 | 1.18 | 1.18 | 1.13 | 1.22 | 1.21 | 1.33 | 1.42 | 1.21 | 1.37 |
| Other Expenses | 1.29 | 1.09 | 0.94 | 1.46 | 1.25 | 1.16 | 1.06 | 0.73 | 1.15 | 1.20 | 1.39 | 0.93 |
| Operating Profit | 1.14 | 0.84 | 0.53 | 1.97 | 0.45 | 0.03 | -0.18 | 0.62 | 0.87 | 1.72 | 0.14 | 1.37 |
| OPM % | 19.4% | 16.1% | 12.3% | 29.7% | 9.3% | 0.8% | -5.1% | 14.5% | 16.2% | 26.1% | 3.1% | 25.5% |
| Profit Before Tax + | 1.18 | 0.86 | 0.56 | 2.02 | 0.50 | 0.05 | -0.16 | 0.65 | 0.89 | 1.75 | 0.16 | 1.41 |
| Tax Expense | 0.32 | 0.20 | 0.16 | 0.59 | 0.13 | 0.02 | -0.05 | 0.19 | 0.23 | 0.44 | 0.10 | 0.30 |
| Tax % | 26.9% | 22.8% | 29% | 29.1% | 26.2% | 37.4% | - | 29.7% | 25.3% | 25.2% | 63.6% | 21.3% |
| Profit After Tax | 0.86 | 0.67 | 0.40 | 1.43 | 0.37 | 0.03 | -0.11 | 0.45 | 0.66 | 1.31 | 0.06 | 1.11 |
| EPS (Basic) | 2.40 | 1.85 | 1.10 | 3.98 | 1.03 | 0.09 | -0.31 | 1.26 | 1.85 | 3.64 | 0.16 | 3.06 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | 21.64 | 16.80 | 22.04 | 20.26 | 9.23 | 7.56 |
| YOY Revenue Growth % | 28.77% | -23.76% | 8.81% | 119.44% | 22.11% | - |
| Other Income | 0.12 | 0.12 | 0.14 | 0.09 | 0.07 | 0.05 |
| Total Income | 21.76 | 16.92 | 22.18 | 20.35 | 9.30 | 7.61 |
| Total Expenses + | 17.55 | 15.88 | 17.56 | 15.73 | 8.24 | 7.48 |
| Cost of Materials Consumed | 5.71 | 6.00 | 8.39 | 7.26 | 3.02 | 2.64 |
| Employee Benefit Expense | 5.34 | 4.74 | 4.12 | 3.58 | 2.34 | 2.03 |
| Other Expenses | 4.67 | 4.21 | 4.79 | 4.32 | 1.99 | 1.96 |
| Operating Profit | 4.09 | 0.92 | 4.48 | 4.53 | 0.99 | 0.08 |
| OPM % | 18.9% | 5.5% | 20.3% | 22.4% | 10.7% | 1% |
| Profit Before Exceptional | 4.21 | 1.04 | 4.62 | 4.62 | 1.06 | 0.13 |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax + | 4.21 | 1.04 | 4.62 | 4.62 | 1.06 | 0.13 |
| Tax Expense | 1.07 | 0.29 | 1.26 | 1.36 | 0.28 | 0.08 |
| Tax % | 25.4% | 28.1% | 27.4% | 29.5% | 26.4% | 59.8% |
| Profit After Tax | 3.14 | 0.75 | 3.36 | 3.26 | 0.78 | 0.05 |
| EPS (Basic) | 8.66 | 2.08 | 9.33 | 9.06 | 2.17 | 0.15 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Non-Current Assets + | 6.07 | 5.86 | 6.67 | 5.73 | 4.71 | 4.80 |
| Property, Plant & Equipment | 3.64 | 3.79 | 4.16 | 3.03 | 2.47 | 2.60 |
| Capital Work in Progress | 0.93 | 0.93 | 0.93 | 1.66 | 1.65 | 1.64 |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 0.17 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 |
| Current Assets + | 19.63 | 17.19 | 15.07 | 10.81 | 7.47 | 6.18 |
| Inventories | 4.83 | 7.03 | 5.74 | 2.98 | 1.66 | 1.96 |
| Trade Receivables | 10.64 | 6.63 | 4.66 | 4.71 | 3.23 | 3.02 |
| Cash and Cash Equivalents | 0.79 | 0.25 | 0.11 | 0.07 | 1.74 | 0.77 |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| LIABILITIES & EQUITY | ||||||
| Total Equity | 18.11 | 13.78 | 13.03 | 9.67 | 6.41 | 5.63 |
| Equity Share Capital | 3.75 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
| Other Equity | 14.36 | 10.18 | 9.43 | 6.07 | 2.81 | 2.03 |
| Non-Current Liabilities | 0.36 | 0.40 | 0.58 | 0.39 | 0.62 | 0.72 |
| Current Liabilities | 7.24 | 8.87 | 8.13 | 6.47 | 5.14 | 4.63 |
| Total Liabilities | 7.60 | 9.26 | 8.71 | 6.87 | 5.76 | 5.35 |
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
| Cash from Operating Activities | 2.92 | -0.01 | -0.12 | 1.74 | 1.61 | 1.09 |
| Cash from Investing Activities | -0.78 | -0.04 | -1.67 | -1.41 | -0.35 | -0.53 |
| Cash from Financing Activities | -1.61 | 0.19 | 1.83 | -1.15 | -0.30 | -0.31 |
| Net Increase/Decrease in Cash | 0.54 | 0.14 | 0.04 | -0.82 | 0.97 | 0.25 |